ArticleFrontiers in immunology2025

Targeting CD16A on NK cells and GPC3 in hepatocellular carcinoma: development and functional validation of a therapeutic bispecific antibody.

Liu Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.